The largest database of trusted experimental protocols

Trisomy

Trisomy refers to the presence of an extra chromosome in a cell, typically involving chromosomes 13, 18, or 21.
This genetic condition can lead to complex developmental and health challenges, depending on the specific trisomy.
PubCompare.ai's AI-driven research platform provides comprehensive analysis of trisomy-related protocols, products, and literature to help identify optimal solutions for your research needs.
Explore curated comparisons across peer-reviewed studies, preprints, and patents to discover the best approaches and leverage cutting-edge insights for your trisomy-focused work.

Most cited protocols related to «Trisomy»

All the analysis of Illumina microarray data was performed in R (42 ). The analysis of the GEO data set is described in more detail in (48 ). As the arrays in this data set were generated from a diverse set of tissues and processed using different normalization methods, direct comparisons between all arrays were not possible. Therefore, the intensities on each array were ranked to investigate the relative expression levels of the probes. The average rank for each bead type across the entire data set was then calculated and used to assess differences between the different annotation categories.
Two separate analyses were performed on the MAQC data. First, a comparison of the MAQC samples run on different Illumina platforms was performed. Normalized data generated from V1 and V2 platforms were taken directly from the published summarized values and the V3 data were BASHed (49 (link)) and summarized using beadarray (50 (link)), and then median normalized. We were then able to look at how particular probes of interest evolved over different versions of the annotation.
The MAQC data generated using Human WG-6 V1 BeadArrays were analyzed to look at the interaction between filtering, differential expression and the annotation categories. Non-normalized MAQC V1 data were read into R and a series of different filtering approaches (Supplementary Data) were applied to all probes. A differential expression analysis was also performed on non-filtered, quantile-normalized, data. The limma (51 ) package was used to find differentially expressed genes, and the log-odds scores given by empirical Bayes moderation of variances (52 ) were used to rank probes.
For the Trisomy study, the data were summarized, quantile-normalized and log2-transformed using beadarray (50 (link)). Differential expression was again quantified by the log-odds after empirical Bayes moderation of variances.
For DASL, data were analyzed and summarized using default BeadStudio settings to provide a 5 × 1506 matrix of observations.
Publication 2009
Genes Homo sapiens Microarray Analysis Tissues Trisomy
Primers spanning the translocation breakpoint were designed using Primer3 software (Broad Institute). The breakpoint primer sequences were Chr17fwd_5′-GTGGCAAGAGACTCAAATTCAAC-3′ and Chr16rev_5′-TGGCTTATTATTATCAGGGCATTT-3′. These primers amplify a ~275 bp product from junction site of the 1716 translocation product. Positive control primers were IMR8545_5′-AAAGTCGCTCTGAGTTGTTAT-3′ and IMR8546_5′-GGAGCGGGAGAAATGGATATG-3′, which amplify a 600 bp product from the Rosa locus. In a 50 μl total reaction, all 4 primers were used at a final concentration of 0.4 μM each. PCR cycling conditions were 94°C – 2min, 94°C – 45sec, 55°C – 45sec, 72°C –1min for 40 cycles, followed by a final 7 min. extension at 72°C – 7min. PCR products were separated on a 1.5% agarose gel. For the purposes of validation, 209 samples that were previously genotyped by either by quantitative PCR (Liu et al. 2003 ) or DNA FISH as being either positive, negative or inconclusive for the segmental trisomy were genotyped by breakpoint PCR. Among this set of samples were samples from Ts65Dn mice and 2 derivative strains, B6EiC3Sn.BLiA-Ts(1716)65Dn/DnJ (The Jackson Laboratory, stock #5252) and B6EiC3Sn-Rb(12.Ts171665Dn)2Cje/CjeDn (The Jackson Laboratory, stock #4850). Additionally, 113 samples derived from Ts65Dn mice and genotyped using the SNP based genotyping prescreen (Lorenzi et al 2010) and FISH confirmation (Moore et al. 1999 (link)).
Publication 2011
Fishes Mus Oligonucleotide Primers Rosa Sepharose Strains Translocation, Chromosomal Trisomy
Indexed paired-end .qseq files were aligned to the mouse reference genome (mm9) using bwa31 (link), and custom scripts were used to split the resulting .bam files by index and to add the chastity flag. The resulting .bam files were sorted and filtered for duplicates (which removes both single-end and dual-end duplicates) and low-quality alignments (q < 20) using Samtools Version 0.1.10 (ref. 32 (link)). We developed a pipeline, BAIT (bioinformatic analysis of inherited templates), that parsed the bam files on the basis of the strand directionality assigned to each read. Reads that mapped to the ‘+’ strand from the first PET (paired-end tag) and the ‘−’ strand reads from the second PET were classified as Watson reads, and reads that mapped to the – strand from the first PET and the + strand from the second PET were classified as Crick reads. These data were plotted as separate histograms against ideograms of mouse chromosomes, with reads counted in 200-kb bins across each chromosome. Additional files in .bed format were plotted over the ideograms to represent sequence gaps and contig orientations. The number of reads mapping to Watson or Crick for each chromosome were summed, and the number of reads per megabase for each chromosome was calculated and printed below the ideograms. Normalized counts per megabase were determined by calculating the sum of both Watson and Crick reads for all autosomes and dividing by the length of the autosomes (in megabases). Any chromosomes in which read counts were 0.66× lower or 1.33× higher than the normalized count were classified as monosomies or trisomies, respectively. SCE events were defined as the interval in which there was a switch from reads mapping to both Watson and Crick strands to reads mapping to just one of the strands, without a corresponding change in the total number of reads such that the sum of Watson and Crick reads remained constant. Our criteria further stipulated that there must be ten consecutive Watson-only or Crick-only reads after the interval switch to count the switch as an SCE or to confirm fragment or contig orientation. To verify SCE and misorientation events, the SCE and misoriented contig interval coordinates were also converted to .bed files using BEDtools33 (link) and uploaded to the UCSC genome browser to identify genomic features and genome build features, such as contigs, and to determine suitable BACs for FISH probes.
Publication 2012
Chromosomes Fishes Genome Mice, House Monosomy Trisomy
BAM files were edited using Picard tools and SNPs were called using the GATK HaplotypeCaller. The SNPs were filtered according to the reading depth and allelic frequency to reduce errors and noise. SNPs with low coverage (below 20 reads) or with low minor allele frequency in the total allele poll (lower than 0.2) were discarded. Next, for each SNP, the major to minor frequency ratio was calculated and the table was sorted by the chromosomal position. For visualization, moving medians of the major to minor ratios were plotted along the moving medians of the chromosomal positions. Usually, a window of 100–150 SNPs was used. The P value was calculated with a one tailed t-test comparing the SNPs major/minor values in the window to the total SNP pool and correcting for multiple testing using FDR correction. In specific cases, to reduce noise, the list of SNPs was further filtered to contain only known SNPs. For the sensitivity assay, reads from diploid (SRR1561108) and trisomy 12 (SRR1561105) samples, from the same study, were mixed in different ratios using the SAMtools view and merge functions. To determine the necessary read number, different percentages of reads, from 10 up to 100% were randomly selected and analysed using eSNP-Karyotyping. The sample selected for this assay had trisomies 12 and 17 (SRR1693240), and covered with more than 50M mapped reads. The entire workflow and visualization of the data were performed using R statistical software (http://www.r-project.org/).
Full text: Click here
Publication 2016
Alleles Biological Assay Chromosomes Diploidy Hypersensitivity Single Nucleotide Polymorphism Trisomy
The National Cancer Institute and institutional review boards of all participating POG institutions approved this study. Written informed consent was obtained from guardians or parents according to the guidelines of the National Institutes of Health. Patients with B precursor ALL aged 1 to 21.99 years first enrolled on the COG P9900 classification/induction study, and received Induction chemotherapy according to NCI risk group. All patients ultimately enrolled in this study received a 4 drug (prednisone, vincristine, asparaginase, daunorubicin) Induction. Patients with an M2 (5–25% blasts) marrow at end Induction (day 29) received 2 additional weeks of therapy with the same agents. Patients who had <5% marrow blasts at day 29 or day 43 were eligible to participate in post-Induction trials for low (P9904), standard (P9905) or high risk ALL (P9906). Patients eligible for the study reported herein (P9906) either met the Shuster age/sex/WBC criteria for higher risk[20 ,23 (link)] (Supplementary Table 1), or they had CNS3 leukemia (5 or more WBC/microliter with blasts present on initial cerebrospinal fluid examination), testicular leukemia, or an MLL translocation. Patients with a Philadelphia chromosome or hypodiploidy (DNA index <0.81 or <45 chromosomes) were not eligible. Patients with the favorable genetic features of ETV6-RUNX1 (formerly TEL-AML1) fusion or trisomies of both chromosomes 4 and 10 were not eligible unless they had CNS3 or testicular leukemia. Diagnostic immunophenotyping, cytogenetic and molecular genetic studies needed to determine information required for eligibility for P9906 were performed at reference laboratories as described previously. [23 (link)]
Publication 2011
Asparaginase Cerebrospinal Fluid Chromosomes Chromosomes, Human, Pair 4 Daunorubicin Diagnosis Eligibility Determination Ethics Committees, Research ETV6 protein, human Induction Chemotherapy Legal Guardians Leukemia Marrow Parent Patients Pharmaceutical Preparations Philadelphia Chromosome Population at Risk Prednisone RUNX1 protein, human TEL-AML1 fusion protein Testis Therapeutics Translocation, Chromosomal Trisomy Vincristine

Most recents protocols related to «Trisomy»

Interphase FISH was performed without sorting on 200 cells from 50 cases from PB, BM or LN samples using a commercial probe panel (MetaSystems, Altlussheim, Germany). Panels included TP53/CEP17 (del17p), ATM (del11q), trisomy 12, D13S29 (del13q), and translocations between IGH and the partner gene (IGH/CCND1). The t(11;14)(q13;q12) IGH/CCND1 dual- color dual- fusion translocation probe was used to identify and rule out cases of mantle cell lymphoma (MCL). Cases with del13q alone or absence of FISH aberrations were categorized as a favorable group according to the Dohner FISH classification (11 (link)), while cases with del11q or del17p were considered unfavorable. The group of patients with trisomy 12 was considered to have an intermediate prognosis. The probe cutoff values were set as 5% for the deletion probe, 3% for the trisomy probe, and 1% for the dual-color dual- fusion probe.
Full text: Click here
Publication 2023
CCND1 protein, human Cells Deletion Mutation Fishes Genes Interphase Mantle-Cell Lymphoma Patients Prognosis TP53 protein, human Translocation, Chromosomal Trisomy
Cytogenetic studies using conventional G‐banding were performed on BM samples. At least 20 metaphases were analyzed whenever possible. Karyotypes were recorded according to the International System for Human Cytogenetic Nomenclature (ISCN) 2013.18 Interphase fluorescence in situ hybridization (FISH) analysis was performed on mononuclear cells of BM aspirates to detect frequent abnormalities such as 5/5q‐, −7, −7q‐, +8, −20/20q‐, and +1/1q + using Vysis LSI EGR1 (5q31), D7S522 (7q31), CEP8, Trisomy 1q (1q25), and D20S108 (20q12) probes (Abott Downers).
Publication 2023
Cells Congenital Abnormality EGR1 protein, human Fluorescent in Situ Hybridization Homo sapiens Interphase Karyotyping Metaphase Trisomy
Human foetal tissues were obtained from the Human Development Biology Resource (HDBR), provided by the Joint MRC/Wellcome Trust (grant #MR/R006237/1) (www.hdbr.org). The HDBR provided fresh tissue from foetuses aged 9–21 post-conception weeks (pcw). Of the 661 samples collected during the 21 month period, the majority were from elective terminations (no abnormality recorded), 62 of the samples were recorded to have a chromosomal trisomy (44 trisomy 21, 12 trisomy 18, 1 trisomy 16, 1 trisomy 13 and 3 triploid). Of the 26 haemorrhagic samples examined, 25 were from elective terminations (no abnormality recorded) and 1 was recorded to have trisomy 21. All tissue was fixed for at least 24 h at 4°C in 4% (wt/vol) paraformaldehyde (PFA) in 120 mM phosphate buffer (pH 7.4). COVID-19 patient lung tissue (Supplementary Fig. 8) was obtained as previously described in Bussani et al.46 (link)
Full text: Click here
Publication 2023
Buffers Chromosome 16, trisomy Chromosomes Complete Trisomy 13 Syndrome Conception COVID 19 Down Syndrome Fetal Tissue Hemorrhage Homo sapiens Joints Lung Manpower paraform Patients Phosphates Tissues Triploidy Trisomy Trisomy 18
Aneuploidy was defined as a loss or gain of the genetic material of chromosome(s), including monosomies, trisomies, polyploidies, segmental aneuploidies, and complex chromosome aneuploidies. In this study, aneuploidy rate of of SA-CV was compered between D5 group and D6 group. Other factors such as age, type of infertility, diagnosed with PCOS were assessed to see if they affected chromosomal results.
Full text: Click here
Publication 2023
Aneuploidy Chromosomes Genetic Materials Monosomy Polycystic Ovary Syndrome Polyploidy Sterility, Reproductive Trisomy
PB or BM aspirates from 80 patients were cultured under stimulated culture conditions and harvested using routine laboratory protocol. Conventional karyotype analysis was performed with G-banded metaphase cells obtained after 72 h of lipopolysaccharide stimulation of the BM aspirates. In each case, at least 20 metaphase cells were assessed, and the cytogenetic abnormalities were interpreted following the 2016 International System for Human Cytogenetic Nomenclature guidelines [64 ].
FISH analysis was performed on 105 patients following the manufacturer’s instructions. Anomalies were detected using five probes: MYB Deletion Probe for del(6q), ATM Deletion Probe for del(11q), Chromosome 12 Alpha Satellite Probe for trisomy 12, RB1 Deletion Probe for del(13q), and TP53 Deletion Probe for del(17p) (Cytocell, Banbury, UK). Slides were prepared using cells harvested for conventional cytogenetic studies and processed for FISH. A total of 400 interphase or metaphase nuclei were examined in each case.
Full text: Click here
Publication 2023
Cell Nucleus Cells Chromosome Aberrations Chromosomes, Human, Pair 12 Deletion Mutation Fishes Homo sapiens Interphase Karyotyping Lipopolysaccharides Metaphase Neutrophil Band Cells Patients TP53 protein, human Trisomy

Top products related to «Trisomy»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in France
The Metasystems XL DLEU/LAMP/12cen and XL ATM/TP53 Multi-Color Probe Kits are laboratory equipment designed for the detection and analysis of specific genetic markers. These probe kits utilize hybridization-based techniques to identify the presence and distribution of target sequences within cell samples. The core function of these products is to provide researchers with the necessary tools for advanced genetic analysis and diagnostics, without extrapolating on their intended use.
Sourced in Canada, United States, Germany
IL-2 is a recombinant cytokine that supports the growth and differentiation of T cells. It is commonly used in cell culture media to promote the expansion of T cell populations.
Sourced in United States, China, India, Australia, Germany, United Kingdom, Canada, Mexico, Italy
The NextSeq 500 platform is a high-throughput DNA sequencing system designed for a wide range of applications. It utilizes sequencing-by-synthesis technology to generate sequencing data. The platform offers fast and efficient DNA sequencing capabilities.
Sourced in Germany, United States, France, United Kingdom, Spain, Netherlands, Italy, Canada, Australia, Japan, Switzerland, Sweden, China
The QIAamp DNA Mini Kit is a silica-membrane-based nucleic acid purification system designed to extract and purify DNA from a variety of sample types. The kit uses a simple spin-column procedure to efficiently capture DNA, which can then be eluted in a small volume of buffer for immediate use in downstream applications.
Sourced in United States, Japan, Germany, United Kingdom, France, Switzerland
The ABI 3130 Genetic Analyzer is a capillary electrophoresis system designed for DNA sequencing and fragment analysis. It utilizes a 4-color fluorescence-based detection system to analyze DNA samples.
Sourced in Germany, United States, France, United Kingdom, Netherlands, Spain, Japan, China, Italy, Canada, Switzerland, Australia, Sweden, India, Belgium, Brazil, Denmark
The QIAamp DNA Mini Kit is a laboratory equipment product designed for the purification of genomic DNA from a variety of sample types. It utilizes a silica-membrane-based technology to efficiently capture and purify DNA, which can then be used for various downstream applications.
Sourced in United Kingdom
HuMEC Ready Medium is a cell culture medium designed for the growth and maintenance of human mammary epithelial cells. It provides the necessary nutrients and growth factors to support the in vitro cultivation of these cell types.
Sourced in United States
The 3130xl DNA Analyzer is a capillary electrophoresis instrument designed for DNA sequencing and fragment analysis applications. It features 16 capillaries and can perform automated sample processing and data analysis.

More about "Trisomy"

Trisomy, also known as chromosome abnormality or aneuploidy, refers to the presence of an extra chromosome in a cell, typically involving chromosomes 13, 18, or 21.
This genetic condition can lead to complex developmental and health challenges, depending on the specific trisomy.
PubCompare.ai's AI-driven research platform provides comprehensive analysis of trisomy-related protocols, products, and literature to help identify optimal solutions for your research needs.
Explore curated comparisons across peer-reviewed studies, preprints, and patents to discover the best approaches and leverage cutting-edge insights for your trisomy-focused work.
Utilize FBS, SAS 9.4, Metasystems XL DLEU/LAMP/12cen and XL ATM/TP53 Multi-Color Probe Kits, IL-2, NextSeq 500 platform, QIAmp DNA Mini Kit, ABI 3130 Genetic Analyzer, QIAamp DNA Mini Kit, and HuMEC Ready Medium to enhance your trisomy research and analysis.
Discover the latest advancements in trisomy-related diagnostics, treatments, and preventive measures through PubCompare.ai's intuitive platform.
Experience seamless research and identify the optimal solution for your trisomy-related needs, leveraging the power of AI-driven insights and comparisons across a vast repository of scientific literature, preprints, and patents.
Explore the world of trisomy with confidence and take your research to new heights.